太阳成tyc122cc(集团)有限公司·搜狗百科

Brief Company Profile

◆ Founded in 2005, Breakeven in 2009, Listed in NEEQ (National Equities Exchange and Quotations, code: 831186) in 2014.

◆ Previously an International Trading and Distribution company. (Import and Distribute Olbetam® from Pfizer in 1999).

◆ 4 Factories: F1-Cephalosporins for Injection, F2-Cephalosporins for Oral, F3-Other Chemical Product for Oral ( e.g. Loxoprofen Soft capsule), F4-TCM for Oral.

◆ Total employees country-wide: 768 (443 sales-men).

Differential Strength

◆ Research Lab – Specialized in Cephalosporin (Oral disintegrating methods, Fruit Flavoring, etc.), very strong abilities on gaining approvals from CFDA, funded by 10% of annual company profit.

◆ Marketing Dpt. – Academic conference member recognized by the government, new release product in the Procurement directory.

◆ Sales Dpt. – Country-wide covered by on field local sales men, office in every Province of China. Specifically strong relationship with Tertiary Hospital and Local Health Centers.

◆ 99% of our sales paid by Cash.

Business Opportunity

 Newly purchase 53450 m² of industrial land in Zhuhai for company expansion.

◆ Expanding sales group all over the country for new release product.

◆ Sourcing Business Development opportunities through company’s Excess funds.

Certification

Inspection – NDA, Uganda

Inspection – FMHACA, Ethiopia

Inspection - NAFDAC

Inspection - DPM Cote d’Ivoire

Powder for Injection Workshop

Oral Preparation Workshop

Powder for Injection

Vial washing

Corridor – Powder

for Injection workshop

Oral products workshop

Products: Dry Suspension, Granules, Chewable Tablets, Oral Dispersible Tablets

Non-Cephalosporin facility

Herbal extract

Hard gelatin capsules, Soft gelatin capsules & tablets

HVAC

Water treatment

Quality Control

QC department has specified area for Physical, chemical and microbial tests.

Equipped with HPLC, GC, IR Spectrometer and UV Spectrometer, etc for all the tests and analysis.

R & D Department

Activities: Regulatory affairs of registration, pilot research and production for formulation and API, etc.